A Genome-wide association study identified HLA-C associated with the effectiveness of methotrexate for psoriasis treatment

J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e898-e900. doi: 10.1111/jdv.17544. Epub 2021 Aug 3.

Authors

Y Zhang¹, X Ding¹, Z Meng¹, M Chen¹, X Zheng¹, M Cai¹, J Wu¹, Y Chang¹, Q Zhang¹, L Jin¹, D Qian¹, X Li¹, M Wu¹, K Yan², Y Lu³, X Zhang^{1

2}

Affiliations

¹ Institute of Dermatology and Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
² Institute of Dermatology and Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
³ Institute of Dermatology and Department of Dermatology, Chengdu Second People's Hospital, Chengdu, China.

PMID: 34310775
DOI: 10.1111/jdv.17544

No abstract available

Publication types

Letter

MeSH terms

Genetic Predisposition to Disease
Genome-Wide Association Study
HLA-C Antigens* / genetics
Humans
Methotrexate / therapeutic use
Psoriasis* / drug therapy
Psoriasis* / genetics

Substances

HLA-C Antigens
Methotrexate

Grants and funding

81773322/Data Center of Management Science, National Natural Science Foundation of China - Peking University